Gene amplification in mesenchymal stem cells and during differentiation towards adipocytes or osteoblasts

Nora Corinna Altmayer; Valentina Galata; Nadine Warschburger; Andreas Keller; Eckart Meese; Ulrike Fischer

doi:10.18632/oncotarget.22804

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Gene amplification in mesenchymal stem cells and during differentiation towards adipocytes or osteoblasts

Nora Corinna Altmayer, Valentina Galata, Nadine Warschburger, Andreas Keller, Eckart Meese and Ulrike Fischer _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2018; 9:1803-1812. https://doi.org/10.18632/oncotarget.22804

Metrics: PDF 1974 views | HTML 2256 views | ?

Abstract

Nora Corinna Altmayer1,*, Valentina Galata2,*, Nadine Warschburger1, Andreas Keller2, Eckart Meese1,* and Ulrike Fischer1,*

1Department of Human Genetics, Saarland University, 66421 Homburg/Saar, Germany

2Chair of Clinical Bioinformatics, Saarland University, 66123 Saarbrücken, Germany

*These authors contributed equally to this work

Correspondence to:

Ulrike Fischer, email: [email protected]

Keywords: gene amplification; CDK4; MDM2; osteoblast; adipocyte

Received: May 27, 2017 Accepted: November 01, 2017 Published: December 01, 2017

ABSTRACT

Gene amplifications are an attribute of tumor cells and have for long time been overlooked in normal cells. A growing number of investigations describe gene amplifications in normal mammalian cells during development and differentiation. Possibly, tumor cells have rescued the gene amplification mechanism as a physiological attribute of stem cells. Here, we investigated human mesenchymal stem cells (hMSCs) for gene amplification using array-CGH, single cell fluorescence in situ hybridization and qPCR. Gene amplifications were detected in mesenchymal stem cells and in mesenchymal stem cells during differentiation towards adipocytes and osteoblasts. Undifferentiated hMSCs harbor 12 amplified chromosomal regions, hMSCs that differentiated towards adipocytes 18 amplified chromosome regions, and hMSCs that differentiate towards osteoblasts 19 amplified regions. Specifically, hMSCs that differentiated towards adipocytes or osteoblasts harbor CDK4 and MDM2 amplifications both of which frequently occur in osteosarcoma and liposarcoma that are both of same cell origin. Beside the amplifications, we identified 36 under-replicated regions in undifferentiated and in differentiating hMSC cells.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 22804

Publication Alerts

Research Papers:

Gene amplification in mesenchymal stem cells and during differentiation towards adipocytes or osteoblasts

Abstract